跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 38 条关于
“PRMT1”
全部
38
临床试验
7
药物
18
机构
0
资讯
13
6个月前
Novel Therapeutic Strategies Target Chemoresistance Mechanisms in Small Cell Lung Cancer
去年
Histone Modifications Drive Tumor-Associated Macrophage Polarization in Cancer Immunotherapy
2个月前
Decoding the PTM Code of cGAS-STING in Gastric Cancer: From Innate DNA Sensing to Precision Combination Therapy
去年
Amgen and Ideaya Terminate Cancer Combination Trial for PRMT5 and MAT2A Inhibitors
去年
Bayer Secures Global License for Novel PRMT5 Inhibitor Targeting MTAP-Deleted Tumors
5个月前
PRMT5 Inhibition Sensitizes B-Cell Lymphoma to Ferroptosis via ATF5-SLC7A11 Axis
去年
IDEAYA Biosciences Submits IND for IDE892 PRMT5 Inhibitor Targeting MTAP-Deleted Lung Cancer
去年
XtalPi's AI-Designed PRMT5 Inhibitor PEP08 Receives Clinical Trial Approvals for Solid Tumors
去年
Tango Therapeutics' PRMT5 Inhibitor TNG462 Shows Promise in Early Trials, Combination Studies Planned
去年
Lupin's PRMT5 Inhibitor LNP7457 Shows Promising Safety Profile in Phase 1 Solid Tumor Trial
第 1 页,共 2 页
上一页
下一页